U.S. Markets open in 5 hrs 27 mins

iShares MSCI Brazil ETF USD Acc (CSBR)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.66-0.09 (-2.40%)
At close: 3:59PM EDT
People also watch
CGNTEYEGCLRBCRTNZSAN
Full screen
Previous Close3.75
Open3.75
Bid0.00 x 0
Ask0.00 x 0
Day's Range3.50 - 4.37
52 Week Range1.56 - 4.79
Volume488,043
Avg. Volume36,765
Market Cap40.21M
Beta-0.53
PE Ratio (TTM)-5.68
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q1, 2018 By the Numbers : September 18, 2017
    Capital Cube8 days ago

    Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q1, 2018 By the Numbers : September 18, 2017

    Categories: Yahoo FinanceGet free summary analysis Champions Oncology, Inc. reports financial results for the quarter ended July 31, 2017. We analyze the earnings along side the following peers of Champions Oncology, Inc. – Aviragen Therapeutics Inc, Charles River Laboratories International, Inc., Exelixis, Inc., Heska Corporation, NanoString Technologies, Inc., Celldex Therapeutics, Inc. and Foundation Medicine, Inc. (AVIR-US, CRL-US, ... Read more (Read more...)

  • Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q4, 2017 By the Numbers : August 1, 2017
    Capital Cube2 months ago

    Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q4, 2017 By the Numbers : August 1, 2017

    Categories: Yahoo FinanceGet free summary analysis Champions Oncology, Inc. reports financial results for the quarter ended April 30, 2017. Highlights Summary numbers: Revenues of USD 3.72 million, Net Earnings of USD -2.42 million. Gross margins widened from 17.45% to 30.89% compared to the same period last year, operating (EBITDA) margins now -63.12% from -88.37%. Change in operating ... Read more (Read more...)

  • Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q3, 2017 By the Numbers : March 22, 2017
    Capital Cube6 months ago

    Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q3, 2017 By the Numbers : March 22, 2017

    Categories: Yahoo Finance Get free summary analysis Champions Oncology, Inc. reports financial results for the quarter ended January 31, 2017. We analyze the earnings along side the following peers of Champions Oncology, Inc. – Aviragen Therapeutics Inc, Charles River Laboratories International, Inc., Exelixis, Inc., Heska Corporation, NanoString Technologies, Inc., Celldex Therapeutics, Inc. and Foundation Medicine, Inc. (AVIR-US, CRL-US, ... Read more (Read more...)